跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Fasrel - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Fasrel
Approved
STANDARD
Fasrel
United Laboratories, Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
63d90513dd5572e2
Company
United Laboratories, Inc
Type
Standard
Approval Details
Approval Id
63d90513dd5572e2
Drug Approval Philippines Name
Fasrel
Product Name
Fasrel
Registration Number
DR-XY46617
Brand Name
Fasrel
Generic Name
Ibuprofen (as Sodium Dihydrate) + Paracetamol
Dosage Form
Film-Coated Tablet
Dosage Strength
200 mg/325 mg
Manufacturer
United Laboratories, Inc
Issuance Date
27 October 2023
Expiry Date
18 June 2029
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID)/Analgesic/Antipyretic
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
63d90513dd5572e2
Type
Standard
Back to Philippines FDA Approvals